Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Cybin Inc. (NYSE AMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
Source: Streetwise Reports 10/12/2023 This company investing in and incubating companies at the forefront of drug policy reform has started...
Cybin shareholders approve the acquisition of Small Pharma with 99.4% of the vote. The post Cybin Shareholders Approve Acquisition of Small Pharma appeared...
• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma LONDON, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc....
Hear from experienced educators and operators on how to navigate the demanding need for education in the space of psychedelic training and therapy. Participants...
Atai Life Sciences AG (Nasdaq: ATAI) clearly believes in the medical technology from IntelGenx Technologies Corp. (OTC: IGXT) as the company has leaned...
–Abstract entitled, “Structure-activity of 2C-X psychedelics to develop a novel 5-HT2A receptor full agonist with therapeutic potential” – –...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
California’s governor has dealt the cannabis industry and marijuana reform supporters a mixed bag of actions on bills. Gov. Gavin Newsom (D) over the...